DE60321684D1 - Zusammenhang von edg5 polymorphism v286a mit diabetes mellitus von typ ii und venenthrombose/lungenembolie und verwendung - Google Patents

Zusammenhang von edg5 polymorphism v286a mit diabetes mellitus von typ ii und venenthrombose/lungenembolie und verwendung

Info

Publication number
DE60321684D1
DE60321684D1 DE60321684T DE60321684T DE60321684D1 DE 60321684 D1 DE60321684 D1 DE 60321684D1 DE 60321684 T DE60321684 T DE 60321684T DE 60321684 T DE60321684 T DE 60321684T DE 60321684 D1 DE60321684 D1 DE 60321684D1
Authority
DE
Germany
Prior art keywords
diabetes mellitus
tentrombosis
venus
typ
context
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60321684T
Other languages
English (en)
Inventor
Detlef Kozian
Evi Kostenis
Karl-Ernst Siegler
Martina Jacobs
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Application granted granted Critical
Publication of DE60321684D1 publication Critical patent/DE60321684D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60321684T 2002-04-09 2003-04-07 Zusammenhang von edg5 polymorphism v286a mit diabetes mellitus von typ ii und venenthrombose/lungenembolie und verwendung Expired - Lifetime DE60321684D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007879 2002-04-09
PCT/EP2003/003569 WO2003085130A1 (en) 2002-04-09 2003-04-07 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof

Publications (1)

Publication Number Publication Date
DE60321684D1 true DE60321684D1 (de) 2008-07-31

Family

ID=28685845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60321684T Expired - Lifetime DE60321684D1 (de) 2002-04-09 2003-04-07 Zusammenhang von edg5 polymorphism v286a mit diabetes mellitus von typ ii und venenthrombose/lungenembolie und verwendung

Country Status (12)

Country Link
EP (1) EP1527197B1 (de)
JP (2) JP4284194B2 (de)
AT (1) ATE398684T1 (de)
AU (1) AU2003240449A1 (de)
CA (1) CA2481300A1 (de)
CY (1) CY1108340T1 (de)
DE (1) DE60321684D1 (de)
DK (1) DK1527197T3 (de)
ES (1) ES2307938T3 (de)
PT (1) PT1527197E (de)
SI (1) SI1527197T1 (de)
WO (1) WO2003085130A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579516B1 (en) 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
JP5904501B2 (ja) * 2010-09-02 2016-04-13 国立研究開発法人理化学研究所 ２型糖尿病の検出方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057126A (en) * 1997-12-24 2000-05-02 Allelix Biopharmaceuticals, Inc. Mammalian EDG-5 receptor homologs
EP1071708A4 (de) * 1998-04-23 2005-01-19 Smithkline Beecham Corp Gen der edg familie, menschliches h218

Also Published As

Publication number Publication date
AU2003240449A1 (en) 2003-10-20
ES2307938T3 (es) 2008-12-01
DK1527197T3 (da) 2008-10-20
CA2481300A1 (en) 2003-10-16
PT1527197E (pt) 2008-09-22
JP4284194B2 (ja) 2009-06-24
ATE398684T1 (de) 2008-07-15
WO2003085130A1 (en) 2003-10-16
JP2005522199A (ja) 2005-07-28
EP1527197B1 (de) 2008-06-18
CY1108340T1 (el) 2014-02-12
JP4956565B2 (ja) 2012-06-20
JP2009171971A (ja) 2009-08-06
EP1527197A1 (de) 2005-05-04
SI1527197T1 (sl) 2008-10-31

Similar Documents

Publication Publication Date Title
DE69435023D1 (de) Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimitteln und diagnostika
ATE438657T1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE3586402D1 (de) Proteinzusammensetzung mit koagulations-wirkung und verfahren zu ihrer herstellung.
ATE278960T1 (de) Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien
DE69131929D1 (de) Methoden zur trans-destabilisierung von spezifischen proteinen in vivo
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
Mizuta et al. Molecular species of collagen from wing muscle of skate (Raja kenojei)
DE60321684D1 (de) Zusammenhang von edg5 polymorphism v286a mit diabetes mellitus von typ ii und venenthrombose/lungenembolie und verwendung
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
NO20053990L (no) Assay for proteinisoformer
DE502005004379D1 (de) Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
CA2366523A1 (en) Method for analyzing the amount of intraabdominal adipose tissue
Brock et al. Characterization of monoferric fragments obtained by tryptic cleavage of bovine transferrin
Aitken Purification and primary structure of cytochrome f from the cyanobacterium, Plectonema boryanum
Cottrell et al. The amino acid sequence of the carboxy-terminal 142 amino acids of the α-chain of human fibrinogen
ATE447045T1 (de) Assoziation von proteinpolymorphismen mit koronarer herzkrankheit
Lindy et al. Hyperchromic effect of collagen induced by human collagenase
DE60125386D1 (de) Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins
Kirschenbaum MOLAR ABSORPTIVITY AND A1% 1cm VALUES FOR PROTEINS AT SELECTED WAVELENGTHS OF THE ULTRAVIOLET AND VISIBLE REGION. VII
DK0420043T3 (da) Antistoffer mod højkonserverede aminosyresekvenser af immunogene stoffer, fremgangsmåde til fremstilling af disse antistoffer samt deres anvendelse ved immunobestemmelser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition